WHO ICTRP trial
Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg…
JPRN-jRCT2080224173 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-jRCT2080224173 |
|---|---|
| Public title | Efficacy and Safety Trial of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure |
| Scientific title | A Multicenter, Double-blind, Randomized, Active-controlled, Parallel-group, Non-inferiority Trial to Evaluate the Efficacy and Safety of OPC-61815 Injection Compared With Tolvaptan 15-mg Tablet in Patients With Congestive Heart Failure |
| Primary sponsor | Otsuka Pharmaceutical Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | 3 |
| Countries | Japan |
| Conditions | Congestive heart failure |
| Interventions | investigational material(s) Generic name etc : OPC-61815 INN of investigational material : Tolvaptan Therapeutic category code : 213 Diuretics Dosage and Administration for Investigational material : Intravenous administration of OPC-61815… |
| Registration date | Jun 12, 2018 |
| Target size | 288 |
| Secondary IDs | NCT03772041;JapicCTI-184234 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: